Elevated Calcium with Normal PTH: Diagnostic Implications
Elevated calcium with normal intact parathyroid hormone (PTH) levels most commonly indicates hypercalcemia of malignancy, with other potential causes including vitamin D intoxication, granulomatous disorders, medications, or familial hypocalciuric hypercalcemia.
Differential Diagnosis
When evaluating a patient with hypercalcemia and normal PTH levels, consider the following causes:
1. Malignancy-Related Hypercalcemia
- Most common non-parathyroid cause of hypercalcemia 1
- Mechanisms:
- Humoral hypercalcemia of malignancy (HHM) via parathyroid hormone-related protein (PTHrP)
- Local osteolytic hypercalcemia
- Ectopic production of 1,25-dihydroxyvitamin D (rare lymphomas)
- Extremely rare: ectopic PTH production by tumors 2
2. Vitamin D-Related Causes
- Vitamin D intoxication
- Granulomatous disorders (sarcoidosis, tuberculosis)
- 1,25-dihydroxyvitamin D production by granulomas
3. Medication-Induced Hypercalcemia
- Thiazide diuretics
- Lithium
- Vitamin A excess
- Calcium supplements
- Newer medications: SGLT2 inhibitors, immune checkpoint inhibitors 1
4. Other Causes
- Thyrotoxicosis
- Adrenal insufficiency
- Immobilization
- Familial hypocalciuric hypercalcemia (FHH)
- Milk-alkali syndrome
Diagnostic Approach
Confirm hypercalcemia - Repeat calcium measurement, preferably with ionized calcium 1
PTH assessment - Key initial test to differentiate PTH-dependent from PTH-independent causes 1
- Normal/elevated PTH with hypercalcemia: Primary hyperparathyroidism
- Suppressed PTH (<20 pg/mL): Non-parathyroid causes
Additional laboratory tests:
- PTHrP measurement
- 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels
- Complete blood count
- Serum and urine protein electrophoresis
- Thyroid function tests
- 24-hour urinary calcium (to rule out FHH)
- Renal function tests
Imaging studies:
- Chest X-ray
- Abdominal imaging (CT/MRI)
- Bone scan if metastatic disease suspected
- Mammography in women
- PET scan if malignancy suspected but not localized
Management Considerations
Acute Management of Symptomatic Hypercalcemia
For severe hypercalcemia (total calcium >14 mg/dL or ionized calcium ≥10 mg/dL):
Hydration - IV fluids (normal saline) to restore intravascular volume 1
Bisphosphonates - Zoledronic acid or pamidronate for malignancy-related hypercalcemia 1
Alternative therapies:
- Denosumab for patients with renal failure
- Calcitonin for rapid but short-term effect
- Glucocorticoids for vitamin D-mediated or granulomatous causes 1
- Dialysis for severe, refractory cases with renal failure
Long-Term Management
Treatment depends on the underlying cause:
Malignancy - Treat the underlying cancer with appropriate therapy 2
Medication-induced - Discontinue offending agent if possible
Granulomatous disorders - Treat with glucocorticoids
Vitamin D intoxication - Discontinue supplements, consider glucocorticoids
Clinical Pearls and Pitfalls
Pearl: While primary hyperparathyroidism and malignancy account for >90% of hypercalcemia cases, the PTH level is the key discriminator 3, 4
Pitfall: Rare cases of ectopic PTH production by tumors can present with elevated calcium and normal/elevated PTH, mimicking primary hyperparathyroidism 2
Pearl: Mild hypercalcemia (calcium <12 mg/dL) is often asymptomatic but may cause fatigue and constipation in about 20% of patients 1
Pitfall: Familial hypocalciuric hypercalcemia can present with elevated calcium and normal/slightly elevated PTH, but is distinguished by low urinary calcium excretion
Pearl: In patients with chronic kidney disease, secondary hyperparathyroidism typically presents with normal or low calcium levels and elevated PTH, not hypercalcemia with normal PTH 5, 6
Remember that hypercalcemia with normal PTH represents a PTH-independent process in most cases, and malignancy should be high on the differential diagnosis, especially in patients without a clear alternative explanation.